Edition:
India

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

27.75USD
8:54pm IST
Change (% chg)

$0.18 (+0.65%)
Prev Close
$27.57
Open
$27.82
Day's High
$27.82
Day's Low
$27.42
Volume
2,962
Avg. Vol
44,527
52-wk High
$29.98
52-wk Low
$16.98

Chart for

About

Dova Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on acquiring, developing and commercializing drug candidates. The Company’s initial focus is on thrombocytopenia, a disorder characterized by a low blood platelet count. The Company is developing avatrombopag for treatment of thrombocyt... (more)

Overall

Beta: --
Market Cap(Mil.): $714.42
Shares Outstanding(Mil.): 25.65
Dividend: --
Yield (%): --

Financials

BRIEF-Dova Pharmaceuticals reports third quarter results

* Dova Pharmaceuticals reports third quarter 2017 operating and financial results

10 Nov 2017

BRIEF-Dova Pharmaceuticals announces New Drug Application submission to FDA

* Dova Pharmaceuticals announces New Drug Application submission to FDA for avatrombopag, a second generation thrombopoietin receptor agonist

22 Sep 2017

BRIEF-Dova Pharmaceuticals qtrly net loss per share, basic and diluted $0.32

* Dova Pharmaceuticals reports second quarter 2017 operating and financial results

11 Aug 2017

BRIEF-Perceptive Advisors reports 6.8 pct passive stake in Dova Pharma

* Perceptive Advisors Llc reports a 6.8 pct passive stake in Dova Pharmaceuticals Inc as of July 5 - SEC filing Source text: (http://bit.ly/2uQUtT6)

01 Aug 2017

BRIEF-Dova Pharma sees IPO to be priced between $15 and $17/shr

* Dova Pharmaceuticals Inc sees IPO of upto 4.06 million shares of common stock to be priced between $15 and $17 per share - SEC filing

19 Jun 2017

Earnings vs. Estimates